LANGE LOUIS G

CIK 00012384019 companiesNAARDEN, P7

SEC Profile

Transactions

Companies

Filings

CIK

0001238401

Recent Transactions

50 trades

Award
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-01-07+3,400→ 10,360 total
Award
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2026-01-07+15,300→ 15,300 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-06-01+68→ 28,186 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Restricted Stock Unit
2025-06-01−68→ 0 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-05-01+69→ 28,118 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Restricted Stock Unit
2025-05-01−69→ 68 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-04-14+69→ 28,049 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Restricted Stock Unit
2025-04-14−69→ 137 total
Award
NewAmsterdam Pharma Co N.V.$NAMS
Restricted Stock Unit
2025-03-26+3,308→ 3,308 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-03-26+3,102→ 10,062 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Restricted Stock Unit
2025-03-26−3,102→ 206 total
Award
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-01-07+6,960→ 6,960 total
Award
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2025-01-06+32,500→ 32,500 total
Purchase
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2024-02-13$19.00/sh+5,000→ 24,878 total
Award
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2024-01-01+10,000→ 10,000 total
Disposition to Issuer
Audentes Therapeutics, Inc.
Stock Option (Right to Buy)
2020-01-15−10,000→ 0 total
Disposition to Issuer
Audentes Therapeutics, Inc.
Stock Option (Right to Buy)
2020-01-15−16,200→ 0 total
Disposition from Tender
Audentes Therapeutics, Inc.
Common Stock
2020-01-15$60.00/sh−13,678→ 0 total
Disposition from Tender
Audentes Therapeutics, Inc.
Common Stock
2020-01-15$60.00/sh−32,343→ 0 total
Disposition from Tender
Audentes Therapeutics, Inc.
Common Stock
2020-01-15$60.00/sh−265,799→ 0 total
Disposition to Issuer
Audentes Therapeutics, Inc.
Stock Option (Right to Buy)
2020-01-15−18,000→ 0 total
Disposition to Issuer
Audentes Therapeutics, Inc.
Stock Option (Right to Buy)
2020-01-15−9,000→ 0 total
Disposition from Tender
Audentes Therapeutics, Inc.
Common Stock
2020-01-15$60.00/sh−3,555→ 0 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2019-12-23$59.60/sh−10,000→ 265,799 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2019-12-23$59.60/sh−1,000→ 13,678 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2019-09-23$32.18/sh−1,000→ 14,678 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2019-09-23$32.66/sh−245→ 275,799 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2019-09-23$32.15/sh−9,755→ 276,044 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2019-06-24$37.89/sh−800→ 15,878 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2019-06-24$39.46/sh−200→ 15,678 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2019-06-24$40.00/sh−600→ 285,799 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2019-06-24$38.15/sh−3,602→ 286,399 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2019-06-24$37.60/sh−15,798→ 290,001 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2019-03-25$36.64/sh−300→ 305,799 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2019-03-25$35.99/sh−19,700→ 306,099 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2019-03-25$35.94/sh−558→ 0 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2019-03-25$36.00/sh−1,000→ 16,678 total
Award
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2019-02-06+16,200→ 16,200 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2018-12-24$18.71/sh−1,000→ 558 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2018-12-24$18.67/sh−20,000→ 325,799 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2018-12-24$18.50/sh−10,000→ 32,343 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2018-12-24$18.70/sh−1,000→ 17,678 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2018-11-15$22.49/sh−20,000→ 345,799 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2018-11-15$22.49/sh−4,000→ 3,555 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2018-09-24$37.27/sh−1,000→ 18,678 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2018-09-24$37.35/sh−19,800→ 365,999 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2018-09-24$37.45/sh−10,000→ 42,343 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2018-09-24$37.25/sh−1,000→ 7,555 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2018-09-24$37.76/sh−200→ 365,799 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2018-09-24$37.27/sh−1,000→ 1,558 total

Companies

Recent Filings

Address

C/O NEWAMSTERDAM PHARMA COMPANY N.V. GOOIMEER 2-35

NAARDEN, P7, 1411 DC

View on SEC.gov